Full Text
PCN3 RITUXIMAB-BASED REGIMEN AS FRONTLINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD NATIONWIDE COHORT STUDY

Abstract

Authors

B.S. Ko H.H. Huang C.Y. Wang H.M. Chen F.Y.S. Hsiao

Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×